Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry

被引:66
作者
Bian, K
Davis, K
Kuret, J
Binder, L
Murad, F
机构
[1] Univ Texas, Sch Med, Dept Integrat Biol Physiol & Pharmacol, Houston, TX 77030 USA
[2] Northwestern Univ, Sch Med, Dept Cell Biol, Chicago, IL 60611 USA
关键词
nitric oxide; peroxynitrite; renal protein nitration; lipopolysaccharide;
D O I
10.1152/ajprenal.1999.277.1.F33
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The presence of nitrotyrosine in the kidney has been associated with several pathological conditions. In the present study, we investigated nitrotyrosine formation in rat kidney after animals received endotoxin for 24 h. With lipopolysaccharide (LPS) treatment, immunohistochemical data demonstrated intense nitrotyrosine staining throughout the kidney. In spite of marked nitrotyrosine formation, the architectural appearance of tubules, glomeruli, and capillaries remained intact when examined by reticulin staining. Our data suggested that the marked staining of nitrotyrosine in proximal tubular epithelial cells was in the subapical compartment where the endocytic lysosomal apparatus is located. Thus a large portion of nitrotyrosine may come from the hydrolysis of nitrated proteins that are reabsorbed by the proximal tubule during the LPS treatment. We also found the colocalization of nitric oxide synthase (NOS-1) and nitrotyrosine within the macula densa of LPS-treated rats by using a double fluorescence staining method. In renal arterial vessels, vascular endothelial cells were more strongly stained for nitrotyrosine than vascular smooth muscle cells. Control animals without LPS treatment showed much less renal staining for nitrotyrosine. The general distribution of nitrotyrosine staining in control rat renal cortex is in the proximal and convoluted tubules, whereas the endothelial cells of vasa recta are major areas of nitrotyrosine staining in inner medulla. The renal distribution of nitrotyrosine in control and LPS-treated animals suggests that protein nitration may participate in renal regulation and injury in ways that are yet to be defined.
引用
收藏
页码:F33 / F40
页数:8
相关论文
共 45 条
  • [1] [Anonymous], 1982, URINARY CONCENTRATIN
  • [2] TOPOGRAPHY OF NITRIC-OXIDE SYNTHESIS BY LOCALIZING CONSTITUTIVE NO SYNTHASES IN MAMMALIAN KIDNEY
    BACHMANN, S
    BOSSE, HM
    MUNDEL, P
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 268 (05): : F885 - F898
  • [3] Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension
    Bosse, HM
    Bachmann, S
    [J]. HYPERTENSION, 1997, 30 (04) : 948 - 952
  • [4] BREDT DS, 1992, J BIOL CHEM, V267, P10972
  • [5] Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo -: A possible role for lipocortin 1
    Bryant, CE
    Perretti, M
    Flower, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 55 (03) : 279 - 285
  • [6] CLAPP WL, 1997, HISTOLOGY PATHOLOGIS, P799
  • [7] IMMUNOSUPPRESSANT FK506 ENHANCES PHOSPHORYLATION OF NITRIC-OXIDE SYNTHASE AND PROTECTS AGAINST GLUTAMATE NEUROTOXICITY
    DAWSON, TM
    STEINER, JP
    DAWSON, VL
    DINERMAN, JL
    UHL, GR
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) : 9808 - 9812
  • [8] Glomerular and vascular tissues do not down-regulate nitric oxide synthesis during protracted endotoxemia
    delCastillo, D
    Agarwal, A
    Jaimes, EA
    Raij, L
    [J]. KIDNEY INTERNATIONAL, 1997, 52 (02) : 460 - 467
  • [9] Effects of L-canavanine, an inhibitor of inducible nitric oxide synthase, on endotoxin mediated shock in rats
    FatehiHassanabad, Z
    Burns, H
    Aughey, EA
    Paul, A
    Plevin, R
    Parratt, JR
    Furman, BL
    [J]. SHOCK, 1996, 6 (03): : 194 - 200
  • [10] CARDIAC AND REGIONAL HEMODYNAMICS, INDUCIBLE NITRIC-OXIDE SYNTHASE (NOS) ACTIVITY, AND THE EFFECTS OF NOS INHIBITORS IN CONSCIOUS, ENDOTOXAEMIC RATS
    GARDINER, SM
    KEMP, PA
    MARCH, JE
    BENNETT, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (03) : 2005 - 2016